跳至主要内容
临床试验/NCT04316715
NCT04316715已完成不适用

Evaluation of Life-Steps to Enhance Adherence and Engagement in PrEP Care

University of Miami4 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2020年9月3日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
300
试验地点
4
主要终点
TFV-DP concentrations

研究概览

简要总结

The purpose of this study is to test how different types of interventions may affect how someone takes their pre-exposure prophylaxis (PrEP) medication.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Age: 18 years or older
  • Male sex at birth or trans man (current gender identity is male) assigned female sex at birth
  • Self-reports as a person who has sex with men
  • PrEP naïve or is currently prescribed PrEP and reports uncertainty about future adherence
  • Medical providers at each site will determine that the participant is indicated for PrEP per Centers for Disease Control (CDC) guidelines
  • Screens in for currently having one or more of the following psychosocial syndemic problems: depression; heavy alcohol use; problematic substance use or polydrug use; history of trauma or abuse; and/or current interpersonal violence
  • Owns a cell phone that has texting and internet / data capacity

排除标准

  • Unable to provide informed consent due to severe mental or physical illness, cognitive impairment, or substance intoxication at the time of interview
  • Discovery of active suicidal ideation or major mental illness (e.g. untreated psychosis or mania) at the time of enrollment (these patients will be referred immediately for treatment, but may join the study when this is resolved)
  • Laboratory or clinical findings that would preclude PrEP initiation (e.g. decreased creatinine clearance)

结局指标

主要结局

TFV-DP concentrations

时间窗: 3, 6, 9, 12, 15, and 18 months

Medication adherence as reported by Tenofovir diphosphate (TFV-DP) concentrations measured using dried blood spot (DBS) testing.

Wilson Medication Adherence self-report

时间窗: up to 18 months

Medication adherence as reported by the Wilson Medication Adherence self-report. The questionnaire has a total score ranging from 0-40, with a higher score indicating greater adherence.

次要结局

  • Retention in PrEP care(3, 6, 9, 12, 15, and 18 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Steven Safren

Professor

University of Miami

研究点 (4)

Loading locations...

相似试验